SLC5A2 and diabetes mellitus: SGLT-2is mitigate against the pathologic hyper-reabsorption of sodium in the early proximal tubule, which is especially beneficial to patients with diabetes because the rise in filtered glucose enhances SGLT-2 activity [135].